Headline News about Pfizer
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
October 29, 2024
Via Benzinga
Key Takeaways From Pfizer Analyst Ratings
October 23, 2024
Via Benzinga
A Closer Look at Pfizer's Options Market Dynamics
October 23, 2024
Via Benzinga
Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
October 29, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Pfizer, Alphabet And 3 Stocks To Watch Heading Into Tuesday
October 29, 2024
Via Benzinga
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
October 23, 2024
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|